Literature DB >> 27771057

Outer membrane vesicles of Gallibacterium anatis induce protective immunity in egg-laying hens.

Susanne E Pors1, Ida J Pedersen2, Ragnhild Bager Skjerning3, Ida C N Thøfner4, Gry Persson5, Anders M Bojesen6.   

Abstract

Gallibacterium anatis causes infections in the reproductive tract of egg-laying hens and induce increased mortality and decreased egg production. New prophylactic measures are needed in order to improve animal welfare and production efficiency. Bacterial outer membrane vesicles (OMVs) have previously shown promising results in protection against infections and we hypothesized that OMVs could serve as an immunogen to protect egg-laying hens against G. anatis. To investigate the immunogenic potential of G. anatis OMVs, two in vivo studies in egg-laying hens were made. The trials assessedthe degree of protection provided by immunization with G. anatis OMV against challenge and the IgY responses in serum after immunization and challenge, respectively. A total of 64 egg-laying hens were included in the trials. OMVs for immunization were produced and purified from a high-producing G. anatis ΔtolR mutant. Challenge was done with G. anatis 12656-12 and evaluated by scoring lesions and bacterial re-isolation rates from peritoneum. Finally, levels of OMV-specific IgY in sera were assayed by ELISA. Immunization with OMVs decreased the lesions scores significantly, while the bacterial re-isolation remained unchanged. Furthermore, a high OMV-specific IgY response was induced by immunization and subsequent challenge of the hens. The results strongly indicate that immunization with G. anatis OMVs provides significant protection against G. anatis challenge and induces specific antibody responses with high titers of OMV-specific IgY in serum. The results therefore show great promise for OMV based vaccines aiming at providing protecting against G. anatis in egg-laying hens.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Egg-laying hens; Gallibacterium anatis; Immunization; Outer membrane vesicles; Protection

Mesh:

Substances:

Year:  2016        PMID: 27771057     DOI: 10.1016/j.vetmic.2016.09.021

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.

Authors:  Fabio Antenucci; Cyrielle Fougeroux; Alannah Deeney; Cathrine Ørskov; Andrew Rycroft; Peter Johannes Holst; Anders Miki Bojesen
Journal:  Vet Res       Date:  2018-01-09       Impact factor: 3.683

2.  Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.

Authors:  Fabio Antenucci; Cyrielle Fougeroux; Janine T Bossé; Zofia Magnowska; Camille Roesch; Paul Langford; Peter Johannes Holst; Anders Miki Bojesen
Journal:  Vet Res       Date:  2017-11-09       Impact factor: 3.683

3.  Clarification of large-volume bacterial cultures using a centrifuge-free protocol.

Authors:  Toloe Allahghadry; Anders Miki Bojesen; Bradley Joseph Whitehead; Fabio Antenucci
Journal:  J Appl Microbiol       Date:  2022-05-16       Impact factor: 4.059

Review 4.  Etiology, epidemiology, pathology, and advances in diagnosis, vaccine development, and treatment of Gallibacterium anatis infection in poultry: a review.

Authors:  Dharanesha Narasinakuppe Krishnegowda; Kuldeep Dhama; Asok Kumar Mariappan; Palanivelu Munuswamy; Mohd Iqbal Yatoo; Ruchi Tiwari; Kumaragurubaran Karthik; Prakash Bhatt; Maddula Ramakoti Reddy
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

5.  Hydrostatic Filtration Enables Large-Scale Production of Outer Membrane Vesicles That Effectively Protect Chickens against Gallibacterium anatis.

Authors:  Fabio Antenucci; Homa Arak; Jianyang Gao; Toloe Allahgadry; Ida Thøfner; Anders Miki Bojesen
Journal:  Vaccines (Basel)       Date:  2020-01-23

Review 6.  RTX Toxins of Animal Pathogens and Their Role as Antigens in Vaccines and Diagnostics.

Authors:  Joachim Frey
Journal:  Toxins (Basel)       Date:  2019-12-10       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.